Current year alerts

September

Philips recall action for CPAP, Bi-Level PAP devices and mechanical ventilators

23 September 2021

Consumer and regulatory updates
Shortages of tocilizumab (Actemra) medicines

21 September 2021

Update on clinical trials guidance and information for pharmacies about ordering Actemra ACTPen and pre-filled syringe from their wholesaler
Substitution instrument to address shortage of Imdur Durules and Monodur Durules isosorbide mononitrate 120 mg modified release tablets

17 September 2021

The TGA has made an SSSI for isosorbide mononitrate 120mg modified release tablets to assist patients to access their medicine without delay.
CHATTANOOGA Ultrasound Gel Products and Lotions

14 September 2021

Recall due to risk of bacterial contamination
Caro white and Carotone products

8 September 2021

Various Caro white and Carotone branded products pose a risk to your health and should not be used.

Advice on the use of tocilizumab (Actemra) intravenous vials post expiry date during the COVID-19 pandemic

30 August 2021

Advice on using tocilizumab (Actemra) vials post expiry date
He Absolute King sachets

30 August 2021

He Absolute King sachets pose a serious risk to your health and should not be taken.
AB SLIM Slim-cellulose capsule

24 August 2021

AB-Slim Slim-cellulose capsules pose a serious risk to your health and should not be taken.
Azide impurity in 'sartan' blood pressure medicines

20 August 2021

TGA investigation - low levels of contamination with azidomethyl-biphenyl-tetrazole (AZBT)
Substitution instrument to address shortage of PROGYNOVA estradiol valerate tablets (multiple strengths)

12 August 2021

The TGA is advising health professionals and consumers of a current shortage for all strengths of PROGYNOVA estradiol valerate tablets.
Tocilizumab (Actemra) Serious Scarcity Substitution Instrument

6 August 2021

The TGA has published the first Serious Scarcity Substitution Instrument (SSSI) for tocilizumab (Actemra) to assist patients to access medicines during the shortage.
Varenicline

5 August 2021

TGA investigation - potential low levels of contamination with N-nitrosovarenicline
Black Ant King tablets

2 August 2021

Black Ant King tablets pose a serious risk to your health and should not be taken.
Neutrogena Ultra Sheer Body Mist Sunscreen Spray SPF 50+ (aerosol sunscreen)

2 August 2021

Recall - Possible presence of benzene

One Night Love tablets

30 July 2021

One Night Love tablets pose a serious risk to your health and should not be taken.
Gold Ant tablets

29 July 2021

Gold Ant tablets pose a serious risk to your health and should not be taken.

Novartis-Bio Somatropin Human Growth Hormone (HGH)

16 June 2021

Counterfeit Somatropin Human Growth Hormone (HGH) vials pose a serious risk to your health and should not be taken.
Ospolot (sulthiame) tablets 200 mg

3 June 2021

Product Defect Alert - child-resistant caps may not function correctly
Zostavax vaccine

2 June 2021

Safety measures to address risk of infection with the vaccine virus

Hydralyte Strawberry Kiwi Effervescent Electrolyte Tablets

21 May 2021

Recall due to unacceptable risk in pregnancy
Shortage of DILAUDID hydromorphone hydrochloride 1mg/mL oral liquid

18 May 2021

Alternative overseas product approved for supply to address DILAUDID (hydromorphone hydrochloride) oral liquid shortage.

Tandem t:slim X2 insulin pump

30 April 2021

Update - suspension lifted after review
AstraZeneca ChAdOx1-S COVID-19 vaccine

23 April 2021

Three additional Australian cases of TTS likely linked to vaccine
AstraZeneca ChAdOx1-S COVID-19 vaccine

16 April 2021

Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine
2021 seasonal influenza vaccines

13 April 2021

Information for consumers and health professionals
AstraZeneca ChAdOx1-S COVID-19 vaccine

13 April 2021

Second case of thrombosis with thrombocytopenia
LIFEPAK CR2 Defibrillator

6 April 2021

Product defect correction - lid magnet may dislodge and cause early battery depletion

Various medicines containing Artemisia annua and Artemisia absinthium

23 March 2021

Recall of various medicines containing Artemisia annua and Artemisia absinthium - updated recalled medicines
AstraZeneca ChAdOx1-S COVID-19 vaccine

19 March 2021

Update - European and UK reviews find no proven link with blood clots
AstraZeneca ChAdOx1-S COVID-19 vaccine

19 March 2021

Update - Expert review finds no evidence of increased risk of anaphylaxis
COVID-19 vaccines - safety and effectiveness in older adults

10 March 2021

Data on real-world use of COVID-19 vaccines approved in Australia provides reassurance about their safety in older people
New legislation to support medicine substitutions

5 March 2021

New legislation has been passed allowing pharmacists to substitute a medicine when the patient's usual medicine is in 'serious scarcity'.
TGA collecting COVID-19 vaccine side effect reports

1 March 2021

Safety monitoring

Shortage of sertraline tablets

16 February 2021

The TGA has issued a Serious Shortage Substitution Notice (SSSN) for sertraline tablets
Resurrection Male Sexual Enhancement Capsules

10 February 2021

Resurrection Male Sexual Enhancement capsules pose a serious risk to your health and should not be taken.
Pregabalin and gabapentin

1 February 2021

Safety advisory - enhanced warnings relating to abuse and dependence

Ergometrine maleate injection (500 microgram/mL) ampoule

21 January 2021

Alternative product approved to address expected shortage
Medicines containing Eucommia ulmoides (known as Du-Zhong or Tu-chung)

13 January 2021

Safety advisory – contains latex (statement includes Chinese translation 中文翻译)